Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors

HOLON, Israel, Sept. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Compugen Ltd. (NASDAQ : CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today the appointment of Jean-Pierre Bizzari, M.D... Biopharmaceuticals, Oncology, Personnel Compugen, immunotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news